{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:51:40Z","timestamp":1767372700272},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1053\/j.semdp.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T05:02:05Z","timestamp":1511931725000},"page":"34-43","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autoimmune and medication-induced lymphadenopathies"],"prefix":"10.1053","volume":"35","author":[{"given":"Alejandro A.","family":"Gru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaci.2016.11.033","article-title":"Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression","volume":"140","author":"Agrebi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"18","key":"10.1053\/j.semdp.2017.11.015_bib2","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.semdp.2017.11.015_bib3","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.semdp.2017.11.015_bib4","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.2015.138081","article-title":"Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation","volume":"102","author":"Xie","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.det.2015.03.006","article-title":"Sarcoidosis","volume":"33","author":"Sanchez","year":"2015","journal-title":"Dermatol Clin"},{"issue":"21","key":"10.1053\/j.semdp.2017.11.015_bib7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1378\/chest.104.2.352","article-title":"Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis","volume":"104","author":"Winterbauer","year":"1993","journal-title":"Chest"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-015-8479-6","article-title":"Pathology of Sarcoidosis","volume":"49","author":"Rossi","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K","article-title":"Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus","volume":"46","author":"Baumann","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/RHU.0b013e3181d56afb","article-title":"Necrotizing lymphadenitis in systemic lupus erythematosus: is it Kikuchi-Fujimoto disease?","volume":"16","author":"Khanna","year":"2010","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.reuma.2016.04.005","article-title":"Lymphadenopathy syndrome in systemic lupus erythematosus: is it Kikuchi-Fujimoto disease?","volume":"13","author":"Salman-Monte","year":"2017","journal-title":"Reumatol Clin"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1191\/096120300678828037","article-title":"Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus","volume":"9","author":"Kitsanou","year":"2000","journal-title":"Lupus"},{"issue":"7\u20138","key":"10.1053\/j.semdp.2017.11.015_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-0463.2005.apm_185.x","article-title":"Reactive hyperplasia with giant follicles in lymph node lesions from systemic lupus erythematosus patients.\u00a0Report of three cases","volume":"113","author":"Kojima","year":"2005","journal-title":"APMIS"},{"issue":"7","key":"10.1053\/j.semdp.2017.11.015_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.prp.2005.05.011","article-title":"Atypical lymphoplasmacytic and immunoblastic proliferation from systemic lupus erythematosus. A case report","volume":"201","author":"Kojima","year":"2005","journal-title":"Pathol Res Pract"},{"issue":"8","key":"10.1053\/j.semdp.2017.11.015_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0344-0338(97)80015-5","article-title":"Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman' disease: a clinicopathologic study of five cases","volume":"193","author":"Kojima","year":"1997","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1440-1827.2000.01052.x","article-title":"Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases","volume":"50","author":"Kojima","year":"2000","journal-title":"Pathol Int"},{"issue":"7","key":"10.1053\/j.semdp.2017.11.015_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/blood-2016-08-736413","article-title":"Kikuchi-Fujimoto disease","volume":"129","author":"Cuglievan","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/134.2.289","article-title":"Kikuchi-Fujimoto disease","volume":"134","author":"Hutchinson","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib20","first-page":"120","article-title":"Kikuchi-Fujimoto disease: a clinicopathologic update","volume":"108","author":"Pepe","year":"2016","journal-title":"Pathologica"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib21","first-page":"329","article-title":"Kikuchi's histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis","volume":"5","author":"Dorfman","year":"1988","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00125480-200307000-00003","article-title":"Kikuchi-Fujimoto lymphadenitis","volume":"10","author":"Onciu","year":"2003","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.semdp.2017.11.015_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms17060900","article-title":"Rheumatoid arthritis: the stride from research to clinical practice","volume":"17","author":"Chung","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J Epidemiol"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jcp.47.2.138","article-title":"Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis","volume":"47","author":"McCluggage","year":"1994","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0142(196908)24:2<343::AID-CNCR2820240217>3.0.CO;2-C","article-title":"Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study","volume":"24","author":"Nosanchuk","year":"1969","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/art.39811","article-title":"Brief report: altered innate lymphoid cell subsets in human lymph node biopsy specimens obtained during the at-risk and earliest phases of rheumatoid arthritis","volume":"69","author":"Rodriguez-Carrio","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib29","first-page":"349","article-title":"Characterization of lymph node histology in adult onset Still's disease","volume":"16","author":"Valente","year":"1989","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/106689690201000305","article-title":"Lymph node lesion in adult-onset Still's disease resembling peripheral T-cell lymphoma: a report of three cases","volume":"10","author":"Kojima","year":"2002","journal-title":"Int J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2017.11.015_bib31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/jcp.2004.018010","article-title":"Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy","volume":"57","author":"Jeon","year":"2004","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2017.11.015_bib32","first-page":"974","article-title":"Splenic involvement in Wegener's granulomatosis","volume":"120","author":"Gal","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib33","first-page":"261","article-title":"Wegener's granulomatosis: histological documentation of common and uncommon manifestations in 216 patients","volume":"26","author":"Lie","year":"1997","journal-title":"Vasa"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0049-0172(97)80013-3","article-title":"Splenic involvement in rheumatic diseases","volume":"27","author":"Fishman","year":"1997","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1053\/j.semdp.2017.11.015_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00043426-200009000-00018","article-title":"Lymph node manifestations of limited Churg-Strauss syndrome","volume":"22","author":"Casey","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2559.1989.tb03080.x","article-title":"Lymph node pathology in Henoch-Schonlein purpura","volume":"15","author":"Akosa","year":"1989","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib37","first-page":"178","article-title":"[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib38","first-page":"81","article-title":"Kawasaki disease. Relationship with infantile periarteritis nodosa","volume":"100","author":"Tanaka","year":"1976","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.semdp.2017.11.015_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/his.12007","article-title":"Histopathological study of lymph node lesions in the acute phase of Kawasaki disease","volume":"62","author":"Yokouchi","year":"2013","journal-title":"Histopathology"},{"issue":"6","key":"10.1053\/j.semdp.2017.11.015_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-198209000-00001","article-title":"Lymph node biopsy for early diagnosis in Kawasaki disease","volume":"6","author":"Giesker","year":"1982","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-4632.2004.02361.x","article-title":"Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two disease entities in the same patient: case report and review of the literature","volume":"45","author":"Chong","year":"2006","journal-title":"Int J Dermatol"},{"issue":"6 Pt 1","key":"10.1053\/j.semdp.2017.11.015_bib42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0190-9622(92)70293-O","article-title":"Kimura's disease and angiolymphoid hyperplasia with eosinophilia: clinical and histopathologic differences","volume":"27","author":"Chun","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.5858\/2007-131-650-KD","article-title":"Kimura disease","volume":"131","author":"Abuel-Haija","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1053\/j.semdp.2017.11.015_bib44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/014556130308201009","article-title":"Kimura disease","volume":"82","author":"Chen","year":"2003","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.otohns.2007.03.027","article-title":"Kimura disease: diagnosis and prognostic factors","volume":"137","author":"Iwai","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjoto.2011.05.005","article-title":"Kimura disease: diagnostic challenges and clinical management","volume":"33","author":"Kapoor","year":"2012","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10.1053\/j.semdp.2017.11.015_bib47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/scs.0b013e3180f61249","article-title":"Kimura disease: diagnostic imaging findings and surgical treatment","volume":"18","author":"Takeishi","year":"2007","journal-title":"J Craniofac Surg"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00000478-200404000-00010","article-title":"Kimura disease: a clinicopathologic study of 21 cases","volume":"28","author":"Chen","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2133.2003.05305.x","article-title":"Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome","volume":"148","author":"Choi","year":"2003","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1053\/j.semdp.2017.11.015_bib50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000478-199506000-00008","article-title":"Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns","volume":"19","author":"Abbondazo","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-017-0626-z","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome and the rheumatologist","volume":"19","author":"Adwan","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1053\/j.semdp.2017.11.015_bib52","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol Int"},{"issue":"10","key":"10.1053\/j.semdp.2017.11.015_bib54","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archderm.1992.01680200081011","article-title":"Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome","volume":"128","author":"D'Incan","year":"1992","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1053\/j.semdp.2017.11.015_bib55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.smj.0000173083.52589.47","article-title":"Necrotizing lymphadenitis associated with the phenytoin-induced hypersensitivity syndrome","volume":"98","author":"Subbannan","year":"2005","journal-title":"South Med J"},{"issue":"6","key":"10.1053\/j.semdp.2017.11.015_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/106002808301700608","article-title":"Phenytoin-induced lymphadenopathy","volume":"17","author":"Schwinghammer","year":"1983","journal-title":"Drug Intell Clin Pharm"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1684\/ejd.2016.2954","article-title":"Pathological findings of lymphadenopathy in drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic syndrome (DRESS): similarities with angioimmunoblastic T-cell lymphoma","volume":"27","author":"Sato","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2017.11.015_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1078\/0171-2985-00200","article-title":"Effective B cell depletion with rituximab in the treatment of autoimmune diseases","volume":"206","author":"Kneitz","year":"2002","journal-title":"Immunobiology"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1309\/5CWPU41AFR1VYM3F","article-title":"Targeted therapies for cancer 2004","volume":"122","author":"Ross","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2017.11.015_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semdp.2012.08.005","article-title":"Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders","volume":"30","author":"Bagg","year":"2013","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2017.11.015_bib61","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2017.11.015_bib62","first-page":"1","article-title":"Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective","author":"Harigai","year":"2017","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.1053\/j.semdp.2017.11.015_bib64","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","article-title":"Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal","volume":"56","author":"Inui","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2017.11.015_bib65","article-title":"EBV-induced lymphoproliferative disorders in rheumatic patients: a systematic review of the literature","author":"Berti","year":"2017","journal-title":"Jt Bone Spine"},{"issue":"10","key":"10.1053\/j.semdp.2017.11.015_bib66","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2017.11.015_bib67","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/PAS.0b013e31828e6564","article-title":"Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases","volume":"37","author":"Loo","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.11.015_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1369073","article-title":"Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression","author":"Tokuhira","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2017.11.015_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2017.1387223","article-title":"Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome","author":"Tsukui","year":"2017","journal-title":"Mod Rheumatol"},{"issue":"2\u20133","key":"10.1053\/j.semdp.2017.11.015_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0379-0738(01)00476-5","article-title":"The 3-week sulphasalazine syndrome strikes again","volume":"122","author":"Lau","year":"2001","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s002960000056","article-title":"Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis","volume":"20","author":"Pay","year":"2000","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1053\/j.semdp.2017.11.015_bib72","first-page":"1029","article-title":"Tissue distribution and deposition of clofazimine in rat following subchronic treatment with or without rifampicin","volume":"45","author":"Mamidi","year":"1995","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00000478-200001000-00016","article-title":"Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient","volume":"24","author":"Sukpanichnant","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2017.11.015_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bms.1200220402","article-title":"Study of intracellular deposition of the anti-leprosy drug clofazimine in mouse spleen using laser microprobe mass analysis","volume":"22","author":"Vandeputte","year":"1993","journal-title":"Biol Mass Spectrom"},{"key":"10.1053\/j.semdp.2017.11.015_bib75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-alpha inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2017.11.015_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-015-3115-7","article-title":"Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses","volume":"35","author":"Chen","year":"2016","journal-title":"Clin Rheumatol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017301491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:36:04Z","timestamp":1660059364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257017301491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0740257017301491"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.015","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune and medication-induced lymphadenopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2017.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}